pper eyelid blepharoplasty investigating 3D and functional outcomes

Recruiting

• Conditions: blefarochalasis, huidoverschot van de bovenoogleden; blepharochalasis; excess skin upper eyelid

• Registration Number: NL-OMON44420
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 54

Inclusion Criteria

- Blepharochalasis of both eyes
- Age between 30 and 60
- Caucasian
- Both male and female patients are included
- Correction of vision between -6 and +6
- Vision of 0.5 or better (with correction)
- Fluent in Dutch
- Legally capable

Exclusion Criteria

- Protruding medial fat compartment
- Ocular trauma in past
- Trauma of the orbital region in the past
- A medical history of eyelid surgery or surgery in the region of the eyebrows.
- Any current ophthalmic disease that could interfere with the ophthalmic tests
- Horner syndrome
- Blepharoptosis
- Graves* disease
- Myasthenia Gravis
- Recent (in the past 6 months) botulin toxin treatment in the upper face
- Nasolacrimal duct obstruction
- Epilepsy
- Retinal defects/diseases that cause visual field defects

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint is orbital change in volume.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes are electrical activity of the frontal and orbicularis oculi<br /><br>muscles, peripheral vision, presence and severity of dry eyes, quality of life<br /><br>and wellbeing.</p><br>